Search Images Maps Play YouTube News Gmail Drive More »
My library | Help | Advanced Book Search | Web History | Sign in

Books

Adherence to Long-term Therapies:

Evidence for Action
Front Cover
Eduardo Sabatâe, World Health Organization
0 Reviews
World Health Organization, 2003 - Medical - 198 pages
Adherence to therapies is a primary determinant of treatment success. Poor adherence attenuates optimum clinical benefits and therefore reduces the overall effectiveness of health systems.

Medicines will not work if you do not take them. Medicines will not be effective if patients do not follow prescribed treatment - yet in developed countries only 50% of patients who suffer from chronic diseases adhere to treatment recommendations. In developing countries, when taken together with poor access to health care, lack of appropriate diagnosis, and limited access to medicines, poor adherence is threatening to render futile any effort to tackle chronic conditions such as diabetes, depression and HIV/AIDS.

This report is based on an exhaustive review of the published literature on the definitions, measurements, epidemiology, economics, and interventions applied to nine chronic conditions and their risk factors. These are: asthma, cancer (palliative care), depression, diabetes, epilepsy, HIV/AIDS, hypertension, tobacco smoking, and tuberculosis.



Intended for clinical practitioners, health managers and policy-makers, this report provides a concise summary of the consequences of poor adherence for health and economics. It also discusses the options available for improving adherence, and demonstrates the potential impact on desired health outcomes and health care budgets. It is hoped that this report will lead to new thinking on policy development, and action on adherence to long-term therapies.





  

What people are saying - Write a review

We haven't found any reviews in the usual places.

Related books

Other editions - View all

Common terms and phrases

Popular passages

Page 148 - Five-year findings of the Hypertension Detection and Followup Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension.
Page 82 - The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
Page 153 - Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
Page 82 - Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Page 82 - National Diabetes Fact Sheet: National estimates and general information on diabetes in the United States. Revised edition.
Page 122 - Anthonisen NR, Connett JE, Kiley JP, et al.: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study.
Page 113 - Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.
Page 104 - A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less.
Page 4 - comprises all impairments or deviations from normal which have one or more of the following characteristics: are permanent; leave residual disability; are caused by nonreversible pathological alteration; require special training of the patient for rehabilitation; may be expected to require a long period of supervision, observation, or care.
Page 59 - ... integrates the psychological and spiritual aspects of patient care; offers a support system to help patients live as actively as possible until death; offers a support system to help the family cope during the patient's illness and in their own bereavement...

References to this book

From other books

Adolescent Rheumatology
A Therapist's Guide to Understanding Common Medical Problems: Addressing a ...
All Book Search results »

From Google Scholar

Adherence to Medication
Lars Osterberg, Terrence Blaschke - 2005 - New England Journal of Medicine
Prevalence, Predictors, and Outcomes of Premature Discontinuation ...
John A Spertus, Richard Kettelkamp, Clifton Vance, Carole Decker, Philip G Jones, John S ... - 2006 - Circulation
How Can We Improve Adherence to Blood Pressure-Lowering Medication ...
Knut Schroeder, Tom Fahey, Shah Ebrahim - 2004 - Archives of Internal Medicine
Compliance in heart failure patients: the importance of knowledge ...
Martje HL van der Wal, Tiny Jaarsma, Debra K Moser, Nic JGM Veeger, Wiek H van Gilst, Dirk J van ... - 2006 - European Heart Journal
All Scholar search results »

References from web pages

Evidence for action
Adherence to long-term therapies:evidence for action. 1.Patient compliance. 2.Long-term care. 3.Drug therapy – utilization. 4.Chronic disease – therapy ...
www.emro.who.int/ ncd/ Publications/ adherence_report.pdf

Adherence to Long-Term Therapies Management: A Call for ...
Progress in Cardiovascular NURSING. Winter 2004. 28. N. oncommunicable diseases such as hypertension,. congestive heart failure, asthma, and diabetes ...
www.blackwell-synergy.com/ doi/ pdf/ 10.1111/ j.0889-7204.2004.02896.x

Sabaté et al. 2003. Adherence to Long-Term Therapies: Evidence for ...
Sabaté et al. 2003. Adherence to Long-Term Therapies: Evidence for Action (WHO). March, 8 2006 14:29. Click Here! Adherence to therapies is a primary ...
hum-molgen.org/ literature/ 03-2006/ 000004.html

European Journal of Cardiovascular Nursing : Adherence to long ...
The World Health Organization (WHO) has recently published a comprehensive report entitled Adherence to Long-Term Therapies: Evidence for Action [1]. ...
linkinghub.elsevier.com/ retrieve/ pii/ S1474515103000914

B D425
Adherence to Long-Term Therapies: Evidence for Action. Edited by Eduardo Sabaté. Published by the World Health Organization,. Geneva, Switzerland, 2003. ...
www.theannals.com/ cgi/ reprint/ aph.1D425v1.pdf

ingentaconnect Adherence to long-term therapies: evidence for action
Adherence to long-term therapies: evidence for action. Authors: De Geest S.; Sabate E.1. Source: European Journal of Cardiovascular Nursing, Volume 2, ...
www.ingentaconnect.com/ content/ els/ 14745151/ 2003/ 00000002/ 00000004/ art00091;jsessionid=3jnf0pe9yimi.alice?format=print

Adherence to long-term therapies: evidence for action.
Adherence to long-term therapies: evidence for action. De Geest S, Sabate E. Publication Types:. Letter. mesh Terms: ...
www.ncbi.nlm.nih.gov/ pubmed/ 14667488

JCDR -
Adherence to Long-Term Therapies Evidence for Action. SHANKAR pr, SUBISH P Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal ...
www.jcdr.net/ article_fulltext.asp?issn=0973-709x& year=2007& volume=1& issue=5& page=452& issn=0973-709x& id=114

Nonadherence to Antiretroviral Therapy in HIV-Infected Patients
Adherence to long-term therapies: evidence for action. Geneva, Switzerland, 2003. Available at: www.who.int/chronic_conditions/adherencereport/en. ...
www.medscape.com/ viewarticle/ 528181_4

Spotlight
Adherence to long-term therapies: Evidence for action. World Health Organisation, 2003. ‘Medicines will not work if you do not take them’ is the simple ...
ije.oxfordjournals.org/ cgi/ reprint/ 32/ 4/ 679.pdf

About the author (2003)

UNAIDS

Bibliographic information